DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,042 filers reported holding DANAHER CORPORATION in Q1 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $184,000 | -37.6% | 1,978 | -42.7% | 0.03% | -46.0% |
Q3 2015 | $295,000 | +74.6% | 3,453 | +74.7% | 0.05% | +38.9% |
Q2 2015 | $169,000 | -43.9% | 1,976 | -44.2% | 0.04% | -14.3% |
Q1 2015 | $301,000 | +4.9% | 3,541 | +3.5% | 0.04% | +20.0% |
Q4 2014 | $287,000 | +10.4% | 3,421 | +0.1% | 0.04% | +20.7% |
Q3 2014 | $260,000 | -13.6% | 3,419 | -12.8% | 0.03% | -17.1% |
Q2 2014 | $301,000 | +56.0% | 3,919 | +49.1% | 0.04% | +45.8% |
Q1 2014 | $193,000 | -14.6% | 2,628 | -10.2% | 0.02% | -22.6% |
Q4 2013 | $226,000 | +11.3% | 2,926 | 0.0% | 0.03% | -13.9% |
Q3 2013 | $203,000 | -23.7% | 2,926 | -30.6% | 0.04% | -45.5% |
Q2 2013 | $266,000 | – | 4,216 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |